Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

Scientists have found a surprising new way to make certain cancer drugs work dramatically better – by helping them get inside ...

Coffee or caffeine can alter circulating levels of sex hormone binding globulin, estrogen, C-peptide, and adiponectin. Coffee ...

The "KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The global market for KRAS inhibitors has seen ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

Nutramax Laboratories Consumer Care, Inc. is pleased to share the results of a newly published human clinical study by Yuan et al., in the Cancer Prevention Research journal.

Targeting IL-37 and IL-38 may offer novel strategies for enhancing NSCLC treatment outcomes Lung cancer remains a significant public ... which enhance tumour cell proliferation and migration. Elevated ...